Hot Features
Registrieren Sie sich für Echtzeit-Benachrichtigungen, benutzerdefinierte Portfolios und Marktbewegungen.
| Datum | Name des Inhabers | Gehandelte Aktien | Wertspanne ($) | Transaktionstyp | Preisspanne ($) | Aktien am Meldungsende | % Veränderung |
|---|---|---|---|---|---|---|---|
| 2026-03-04 | Ms. Jennifer B. DamicoSenior VP, Controller & Principal Accounting Officer | -826,00 | 21,99k | Sale to Issuer | 26,62 | 32,93k | -2,45% |
| 2026-02-27 | Ms. Jennifer B. DamicoSenior VP, Controller & Principal Accounting Officer | -655,00 | 18,11k | Sale to Issuer | 27,65 | 12,04k | -5,16% |
| 2026-02-25 | Ms. Jennifer B. DamicoSenior VP, Controller & Principal Accounting Officer | 510,00 | 17,25k | Derivative Exercise and Retained Stock | 33,82 | 12,70k | 4,19% |
| 2026-02-25 | Ms. Jennifer B. DamicoSenior VP, Controller & Principal Accounting Officer | -17,05k | 117,57k | Derivative Exercise and Sale | 26,92 - 33,82 | 12,70k | - |
| 2026-02-25 | Ms. Payal Sahni BecherChief People Experience Officer & Exec. VP | 1,74k | 58,81k | Derivative Exercise and Retained Stock | 33,82 | 42,30k | 4,29% |
| 2026-02-25 | Ms. Payal Sahni BecherChief People Experience Officer & Exec. VP | -55,15k | 380,34k | Derivative Exercise and Sale | 26,92 - 33,82 | 42,30k | - |
| 2026-02-25 | Mr. Douglas M. LanklerExec. VP & Chief Legal Officer | 3,90k | 131,83k | Derivative Exercise and Retained Stock | 33,82 | 165,26k | 2,42% |
| 2026-02-25 | Mr. Douglas M. LanklerExec. VP & Chief Legal Officer | -119,01k | 820,79k | Derivative Exercise and Sale | 26,92 - 33,82 | 165,26k | - |
| 2026-02-25 | Mr. Michael McDermottExec. VP and Chief Global Supply & Quality Officer | -37,93k | 261,35k | Derivative Exercise and Sale | 26,92 - 33,82 | 74,31k | - |
| 2026-02-26 | Mr. Michael McDermottExec. VP and Chief Global Supply & Quality Officer | -2,30k | 62,36k | Sale to Issuer | 27,10 | 74,31k | -3,00% |
| 2026-02-25 | Dr. Albert BourlaChairman of the Board & CEO | 16,08k | 543,89k | Derivative Exercise and Retained Stock | 33,82 | 394,67k | 4,25% |
| 2026-02-25 | Dr. Albert BourlaChairman of the Board & CEO | -475,54k | 3,28M | Derivative Exercise and Sale | 26,92 - 33,82 | 394,67k | - |
| 2026-02-25 | Ms. Lidia L. FonsecaInsider | 1,76k | 59,66k | Derivative Exercise and Retained Stock | 33,82 | 46,46k | 3,95% |
| 2026-02-25 | Ms. Lidia L. FonsecaInsider | -55,12k | 380,18k | Derivative Exercise and Sale | 26,92 - 33,82 | 46,46k | - |
| 2026-02-25 | Dr. Chris BoshoffChief Scientific Officer and President of Research & Development | -6,83k | 185,11k | Sale to Issuer | 27,09 | 162,09k | -4,05% |
| 2026-02-23 | Dr. Chris BoshoffChief Scientific Officer and President of Research & Development | -816,00 | 22,08k | Sale to Issuer | 27,06 | 155,54k | -0,52% |
| 2026-02-23 | Ms. Jennifer B. DamicoSenior VP, Controller & Principal Accounting Officer | -419,00 | 11,34k | Sale to Issuer | 27,06 | 12,19k | -3,32% |
| 2026-01-30 | Dr. Chris BoshoffChief Scientific Officer and President of Research & Development | -12,89k | 340,73k | Sale to Issuer | 26,44 | 156,34k | -7,62% |
Die zuletzt besuchten Aktien werden in diesem Feld angezeigt, so dass Sie leicht zu den Aktien zurückkehren können, die Sie zuvor angesehen haben.
Support: +44 (0) 203 8794 460 | support@advfn.de
Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen
Mit E-Mail registrieren
Haben Sie schon ein Konto? Anmelden
Haben Sie kein Konto? Registrieren
Durch die Registrierung bestätige ich, dass ich die Allgemeinen Geschäftsbedingungen von ADVFN gelesen und verstanden habe und ihnen zustimme und dass ich ein Privatinvestor bin.
Premium
